Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura
JB Bussel(NewYork–Presbyterian Hospital), MW Hilgartner, J O'Malley(Hospital for Special Surgery), Charlotte Cunningham-Rundles(Hospital for Special Surgery), Robert P. Kimberly(Regeneron (United States)), I Schulman(Hospital for Special Surgery), RD Inman(Hospital for Special Surgery), N K Cheung(Memorial Sloan Kettering Cancer Center), EM Smithwick(Hospital for Special Surgery), S Barandun(Hospital for Special Surgery)
Cited by 299
Related Papers
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
|Annals of the Rheumatic Diseases|2011|988
A More Uniform Measurement of Factor VIII Inhibitors
|Thrombosis and Haemostasis|1975|587
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
|The Journal of Immunology|2006|487
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
|Journal of Clinical Oncology|1987|417